Pevion appoints Didier Hoch as Chairman of the Board
Pevion Biotech Ltd. announced the appointment of Didier Hoch as Chairman of its Board of Directors. Until recently, Dr Hoch was President of Sanofi-Pasteur MSD, where he played a pivotal role in launching innovative vaccines, such as Gardasil®, in Europe.
Prior to his position as President of Sanofi-Pasteur MSD from 2000 until 2010, Didier Hoch was Vice President Africa & Middle East at Aventis Pharma International, and before that he was Deputy General Manager at Rhône-Poulenc Rorer France. From 2003 until 2009 Dr Hoch was President of the European Vaccine Manufacturers Association (EVM) and was Vice-President in 2002 and in 2010. Furthermore, he is President of the Biotechnology Committee of LEEM (the French pharma industry association) and President of the Life Science Health Committee of MEDEF (the French global industry association). He graduated in Medicine from the University of Lyon, France.
Pevion also announced that its shareholders have appointed Daniel Richner, BZ Bank, as new member of the Board, replacing Dr Joseph Manko. Dr Richner has been working in the financial industry for 24 years, among others for the Lombard Odier Immunology Fund and HBM Bioventures. He joined BZ Fund Management in 2010, where he coordinates investments in the life sciences.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
